Altimmune, Inc. — Director's Dealing 2010

Jun 22, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PHARMATHENE, INC (PIP)
CIK: 0001326190
Period of Report: 2010-06-17

Reporting Person: RICHMAN ERIC I (Director, President and Interim CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-06-17	Common Stock, $0.0001 par value per share	P	10000	$1.5767	Acquired	70573	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices
ranging from $1.56 to $1.58 per share. The reporting person undertakes to provide to PharmAthene, Inc., any security holder
of PharmAthene, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the
number of shares purchased by him at each separate price on June 17, 2010.